Biotech lab develops blueprint to fast-track coronavirus vaccine production

Drugmaker AstraZeneca’s vaccine is now in advanced trials and the company says it has the capacity to make 3 billion doses when the vaccine is ready. Charlie D’Agata has the latest in CBS News’ series “Racing to a Cure.” Source